Moderna stock rises on flu vaccine data and FDA approvals, while healthcare stocks remain under pressure amid political ...

1 Introduction COVID-19 is caused by infection with SARS-CoV-2 and remains an ongoing public health threat (1). The development and widespread availability of COVID-19 vaccines, including previously ...

As of June 22, there were 1,648 cases of the new variant reported across 38 countries. In the UK, the latest data by the UK ...

The Department of Health investigates an incident involving a private doctor administering COVID-19 vaccines that exceeded ...

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

Notable among these examples is that of a 16-year-old boy, who was found with a large number of vaporiser pods in his home.

Moderna (MRNA) stock in focus as the company cancels plans for an mRNA manufacturing plant in Japan amid a challenging ...